EXCRETION OF URINARY 17-HYDROXYCORTICOSTEROIDS AND 11-DEOXY-17-OXOSTEROIDS BY WOMEN USING STEROIDAL CONTRACEPTIVES
Authors:
- R.D BulbrookRBR.D Bulbrook
- J.L HaywardJHJ.L Hayward
- 1 November 1969
- journal article
- Published by Elsevier in The Lancet
- Vol. 294 (7629) , 1033-1035
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Effect of the Administration of Estrogen on the Disappearance of3H-testosterone in the Plasma of Human SubjectsThe Journal of Clinical Endocrinology & Metabolism, 1969
- Carcinoma of prostate: response of plasma luteinizing hormone and testosterone to oestrogen therapy.BMJ, 1968
- Serum Protein Alterations Produced in Women by Synthetic EstrogensThe Journal of Clinical Endocrinology & Metabolism, 1967
- ABNORMAL URINARY STEROID EXCRETION AND SUBSEQUENT BREAST CANCERThe Lancet, 1967
- Steroid-Protein Interaction with Particular Reference to Testosterone Binding by Human SerumJournal of Biological Chemistry, 1967
- The Secretion and Metabolism of Cortisol and Aldosterone in Normal and in Steroid-Treated Women*The Journal of Clinical Endocrinology & Metabolism, 1962
- ENDOCRINOLOGIC AND METABOLIC EFFECTS OF 17α-METHYL-19-NORTESTOSTERONE IN WOMEN*†The Journal of Clinical Endocrinology & Metabolism, 1960
- THE SUPPRESSION OF ADRENOCORTICAL SECRETION WITH 17α-ETHYL-19-NORTESTOSTERONEJournal of Endocrinology, 1957